Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. Y P Zhou, V E Grill J Clin Invest. 1994;93(2):870-876. https://doi.org/10.1172/JCI117042. We tested effects of long-term exposure of pancreatic islets to free fatty acids (FFA) in vitro on B cell function. Islets isolated from male Sprague-Dawley rats were exposed to palmitate (0.125 or 0.25 mM), oleate (0.125 mM), or octanoate (2.0 mM) during culture. Insulin responses were subsequently tested in the absence of FFA. After a 48-h exposure to FFA, insulin secretion during basal glucose (3.3 mM) was several-fold increased. However, during stimulation with 27 mM glucose, secretion was inhibited by 30-50% and proinsulin biosynthesis by 30-40%. Total protein synthesis was similarly affected. Conversely, previous palmitate did not impair alpha-ketoisocaproic acid (5 mM)-induced insulin release. Induction and reversibility of the inhibitory effect on glucose-induced insulin secretion required between 6 and 24 h. Addition of the carnitine palmitoyltransferase I inhibitor etomoxir (1 microM) partially reversed (by > 50%) FFA-associated decrease in secretory as well as proinsulin biosynthetic responses to 27 mM glucose. The inhibitory effect of previous palmitate was similar when co-culture was performed with 5.5, 11, or 27 mM glucose. Exposure to palmitate or oleate reduced the production of 14CO2 from D-[U-14C]glucose, and of 14CO2 from D-[3,4-14C]-glucose, both effects being reversed by etomoxir. Conclusions: long-term exposure to FFA inhibits glucose-induced insulin secretion and biosynthesis probably through a glucose fatty acid cycle.
Introduction
The importance of FFA in the regulation of insulin secretion has not been thoroughly assessed. During nonstimulatory conditions, endogenous triacylglycerols are important fuels for intermediary metabolism of pancreatic islets (1) . However, effects on insulin secretion are less impressive. Although FFA have been shown in vivo and in vitro to stimulate insulin secretion (2, 3) , such stimulation is usually moderate, suggesting that FFA do not play a major role in regulation of insulin secretion.
Theoretically, elevated FFA, such as occur during starvation and diabetes, could influence insulin secretion in a major way if a glucose-fatty acid cycle were operative in the B cell. The concept of such a cycle was proposed by Randle et al. (4) many years ago. It encompasses the notion that the relationship between glucose and fatty acid breakdown is reciprocal and not dependent. Accordingly, increased oxidation of fatty acids, such as occurs in fasting and diabetes, will inhibit the metabolism ofglucose (by several mechanisms, see reference 5 for review). This relationship between fatty acid oxidation and glucose metabolism has been documented in tissues such as heart muscle and liver (5) . However, the existence ofa glucose fatty acid cycle has not been demonstrated in pancreatic islets. Rather, most previous studies have seemed to disprove its existence. Hence in short-term experiments fatty acid oxidation did not negatively affect glucose oxidation (6) . Furthermore, in a detailed study on the effects of a carnitine palmitoyl transferase I(CPT I)' inhibitor, methyl-palmoxirate, this inhibitor of long-chain fatty acid oxidation failed to affect D-[U-"C]glucose oxidation, and did not enhance but, instead, diminished glucose-induced insulin release (7) . More recently the CPT I inhibitor 2-bromopalmitate was shown to enhance glucose-induced insulin secretion in a clonal ,B cell line of HIT cells (8) . However, it is difficult to decide whether these results in insulinoma cells are applicable to normal B cells.
Previous studies utilized mostly short-term protocols to study the interactions between FFA and glucose. It seemed possible that long-term exposure to FFA could induce effects different from those exerted by short-term exposure. This hypothesis was tested by infusing a lipid solution, Intralipid, for varying durations into rats (9) . Glucose-induced insulin secretion was measured subsequent to infusion using the perfused pancreas. The effects of Intralipid turned out to be biphasic in time. After 3 h of infusion, glucose-induced insulin secretion was enhanced whereas it was decreased after 24 h and even more so after 48 h of infusion. These results indicated that the long-term hyperlipidemia inhibited glucose-induced insulin secretion.
Hyperlipidemia induces insulin resistence (10, 11 ) as well as many changes in nutrient and hormonal levels, all of which could potentially affect B cell function. Although the infusion experiments provided some data suggesting that the effects observed were related to fatty acid oxidation (9), they did not provide definite evidence that the, effects of hyperlipidemia were directly caused by elevated FFA. Furthermore, even if such were the case, the relevance to physiology would be in doubt since Intralipid contains a much higher proportion of unsaturated fatty acids than plasma, its major fatty acid component being linoleic acid (9) , whereas the dominating FFA in plasma are oleic and palmitic acid. The first aim ofthe present study was therefore to directly test for time-dependent effects of different concentrations of palmitate and of oleate on glucose-induced insulin secretion. The Animals. Male Sprague-Dawley rats were obtained from B & K Universal, Stockholm, Sweden. They had free access to water and a standard pelleted diet (EWOS-ALAB Brook Stock Feed for rats and mice). The pellets contained on a weight basis 51.5% carbohydrate, 22% protein, and 5% fat. They were exposed to a 12-h/ 12-h light (0600-1 800)/dark cycle. At the time of experiments they weighed between 200 and 300 g. The experimental protocols were approved by the Stockholm Ethical Committee for Research on Animals.
Isolation and culture ofislets. Animals were killed by decapitation and pancreatic islets of Langerhans isolated as previously described ( 12) , using digestion with collagenase obtained from Clostridium histolyticum (Boehringer Mannheim Gmb H, Mannheim, FRG). Digestion and sedimentation of islets were carried out in Hanks' solution containing 5.5 mM glucose (Statens Bakteriologiska Laboratorium, Stockholm). Islets were then handpicked under a stereomicroscope and transferred to Petri dishes (Steriline, Teddington, UK) containing culture medium RPMI 1640 (Flow Laboratories, Erwing, UK) supplemented with 100 U/ml benzylpenicillin, 0.1 mg/ml streptomycin, 2 mM L-glutamine, and 10% (vol/vol) heat-inactivated fetal calf serum (Sigma Chemical Co.). The concentration of glucose in culture media was 11.0 mM when not otherwise indicated. Islets were cultured freefloating at 370C, with an atmosphere of 5% C02/95% air. The time period of culture was 48 h except in time course studies of induction and reversibility. Islets were cultured for 48 h in RPMI 1640 with 11 mM glucose, containing ethanol and etomoxir at the concentrations listed; insulin release was determined in 60-min final incubations. No significant differences were found between experimental conditions. Fatty acids (sodium salts) were dissolved in 95% ethanol before being added to culture media. The final concentration of ethanol in medium was 1% or 2% (vol/vol) at the concentrations of FFA used in this study. Neither of the concentrations used during culture affected the subsequently tested insulin release nor islet insulin content (Table   I ). Control conditions with 1% or 2% ethanol during culture were included in each experiment.
Batch-type incubations of islets. After 48 h of culture in RPMI 1640, islets were always preincubated for 30 min in KRB medium ( 13) with the following composition: Na' 143.5 mM, K+ 5.8 mM, Ca2' 2.5 mM, Mg2" 1.2 mM, CP-124.1 mM, PO3-1.2 mM, SO"4 1.2 mM, CO`25 mM, pH 7.4, and supplemented with 10 mM Hepes, 2 g/liter BSA (fraction IV, Sigma Chemical Co.), and 3.3 mM glucose. Except for variations in glucose, this buffer was used throughout the study.
For insulin secretion studies, islets were selected after preincubation in batches of three islets in 200 M1 of KRB containing either 3.3 or 27 mM glucose. Islets were incubated at 370C for 60 min. Triplicates or quadruplicates were run for each experimental condition. Incubations were carried out in a water bath with continuous shaking and in an atmosphere of 95% 02/ 5% CO2. At the end of incubations, aliquots of the incubation media were removed for insulin assay. Islets which, in final incubations, were exposed to 3.3 mM glucose were retrieved for later determination of islet insulin content. Proinsulin and total protein biosynthesis. For the study of proinsulin-insulin and total protein biosynthesis, groups of 10 islets were incubated as duplicates in polystyrene RIA tubes containing 100 l1 ofKRB medium supplemented with 50 ,uCi/ml L-[4,5-3H]-leucine and 3.3 or 27 mM glucose at pH 7.4 for 2 h at 37°C (without shaking) in 95% 02/5% C02. After incubations, the medium containing radioactive leucine were carefully removed by suction. The islets were then washed twice with Hanks' solution containing nonradioactive leucine (10 mM). The washed islets were sonicated in 200 Ml of redistilled water (10 X 2 s., model B-12 sonifier, setting 4; Branson Ultrasonics Corp., Danbury, CT). The sonicates were then centrifuged ( 10,000 g, 10 min) at 4°C and the supernatants were used for subsequent analysis.
Proinsulin-insulin biosynthesis was measured by immunoprecipitation with undiluted antiinsulin serum (in excessive amount), and separation of immune complexes with protein A Sepharose CL-4B as described ( 14) . Total protein synthesis was determined by measurements of the radioactivity in the 10% TCA-precipitable fraction of the homogenate.
Glucose oxidation. The production of 14CO2 from D-[U-14C]glucose was measured basically as previously described ( 15) . Briefly, duplicate groups of 10 islets each were placed in wells (central well, Kontes Co., Vineland, NJ) containing 100 ,u of KRB medium supplemented with trace amounts of D-[U-_4C] glucose plus nonradioactive glucose to a final concentration of either 3.3 or 27 mM. The wells were suspended in 20-ml scintillation vials, which were gassed with 02/C02 (95:5) and capped airtight with rubber membranes. The vials were shaken continuously for 90 min at 37°C in a water bath. Islet metabolism was stopped by an injection of 100 ,ul of 0.2 M HCl into the wells. This was immediately followed by injection of 250 ,ul of hyamine hydroxide into the outer vial. After a further incubation for 2 h at 370C to allow the liberated CO2 to be trapped by the hyamine, 5 ml ofscintillation fluid was added to each vial and the radioactivity was counted in a Packard Instruments Tricarb model 1900 TR scintillation analyzer. Blank incubations were treated identically. Oxidation of glucose was calculated as picomoles ofglucose converted to [14C] CO2 per 10 islets/ 90 min.
The procedure used to measure the generation of '4C02 from D- [3,4- '4C]glucose was identical to that for D-[U-_ 4CIglucose oxidation described above except for using 50 ,ul of KRB, which contained 0.4-1.0 ,uCi/ml D-[ 3,4-'4C]glucose, and 120 min for incubation as previously reported ( 16) .
Measurements of insulin release and islet insulin content. Insulin was measured by RIA using rat insulin as standard, monoiodinated porcine insulin as tracer, and charcoal premixed with Dextran T 70 (Pharmacia, Uppsala) to separate antibody bound insulin from free Fatty Acids and B Cell Dysfunction 871 insulin (17) . Insulin antibodies had been raised in our laboratory against porcine insulin.
For the determination of islet insulin contents, three islets each were put into 200 Ml of acid-ethanol (0.18 M HCO in 95% ethanol); insulin was extracted overnight at 40C after sonification as previously described (18) .
Presentation of results. All results are expressed as the mean±SE. Significance testing was performed using two-tailed Student's t test for unpaired data and one-way ANOVA with the Student-Newman-Keuls' test.
Results
Effects ofa 48-h exposure to FFA on glucose-induced insulin secretion and insulin content. The effects of48 h ofculture with palmitate, oleate, or octanoate are shown in Table II . Previous exposure to all three fatty acids increased fourfold or more insulin release during subsequent incubations with 3.3 mM glucose, i.e., a nonstimulating concentration of the hexose. Contrariwise, all these three fatty acids inhibited insulin release during stimulation with 27 mM glucose. With palmitate, inhibition was more marked after 0.25 mM than after 0.125 mM of this fatty acid. At equimolar concentrations of 0.125 mM, the inhibitory effect after previous palmitate was 30%, and after previous oleate 42%. The incremental response to 27 mM glucose was inhibited by 82% after palmitate and by 86% after oleate. All three fatty acids reduced islet insulin contents (Table II). At equal concentrations (0.125 mM), the reduction was 23% after palmitate and 40% after oleate. Influence of etomoxir on FFA-induced changes of insulin secretion. Etomoxir, one ofthe mitochondrial CPT I inhibitors containing oxirane carboxylates (19, 20) , was used to test whether inhibition of the :-oxidation oflong-chain fatty acids, such as palmitate and oleate, could reverse their effects on insulin secretion (Table II) . Addition of 1 gM etomoxir to culture media did not per se influence basal or glucose-induced insulin secretion (Table I) . Addition of etomoxir to culture media containing fatty acids did not significantly affect the fatty acidstimulated insulin secretion in the presence of 3.3 mM glucose. Etomoxir during culture with palmitate or oleate partially (by 75% for 0.125 mM palmitate, and by 48% for 0.125 mM oleate) reversed the inhibitory effects of these fatty acids on insulin response to 27 mM glucose.
Flwithout Etomoxir Uwith Etomoxir
Specificity of the etomoxir effect was tested by adding the CPT I inhibitor to culture media containing octanoate. The oxidation of this fatty acid is known not to involve the CPT enzyme (21 ) . In our experiments, previous etomoxir together with octanoate failed to significantly affect the inhibitory effect on glucose-induced insulin secretion exerted by culture with this fatty acid (Table II) .
Etomoxir partially reversed the reduction in islet insulin content brought about by palmitate or oleate. However, the reduction in islet insulin content brought about by octanoate was not affected.
In another series of experiments, etomoxir was added from preincubation and onward, but not during culture. Also in these experiments, etomoxir partially reversed FFA-associated impairment of 27 mM glucose-induced insulin secretion (Fig.  1 ). Finally, exposure to etomoxir was tested from the begin- Table III , the basal insulin secretion at 3.3 mM glucose was elevated near-maximally already after 6 h of palmitate exposure when compared with control conditions (culture at RPMI 1640 with 1% ethanol). In contrast, the insulin response to 27 mM glucose was significantly reduced only after 24 h exposure. A 48-h exposure was needed to induce a marked effect (lowering to 50% of the control).
Insulin contents in palmitate-exposed islets were reduced already after a 6-h exposure (to 60% of the control). With longer exposure, the absolute values decreased further; however, due to some reduction with time of culture in insulin contents ofcontrol islets, there was no further drop in the ratio of insulin content between palmitate-exposed and control islets.
The same experiments which were used to evaluate induction were continued to assess also the time ofreversibility. Islets which had been exposed to palmitate or ethanol for 48 h (and not used for measurements of induction)were transferred to standard RPMI 1640 medium with 1 1.0 mM glucose and 2 mM L-glutamine but without palmitate. After 6 h of recovery culture, the influence ofpalmitate exposure persisted both with regard to the increased basal and decreased stimulated insulin secretion (Fig. 2 ). However, after 24 h, both basal and stimulated insulin secretion were restored to normal. Insulin contents in these islets also increased significantly (from 29±2.7 ng/islet at 6 h, to 38±55.4 ,uU/islet at 24 h); however, these contents were still lower than those of control condition (47±2.2 ng/islet, P < 0.01).
Effect ofglucose concentration during culture on effects of palmitate. To evaluate the possible interaction between hyperglycemia and FFA on glucose-induced insulin release, the exposure of islets to 0.125 mM palmitate were compared for three different glucose concentrations (5.5, 11.0, and 27 mM) during culture. Increasing the glucose concentration from 5.5 to 11 mM did not affect basal release at 3.3 mM glucose in control culture. However, the increase in glucose during culture augmented the stimulatory effect of palmitate at 3.3 mM glucose (Table IV) . Increasing the glucose concentration to 27 mM led to 5.7-fold higher release at 3.3 mM glucose. Co-culture of palmitate with 27 mM glucose did not further increase subsequent release at 3.3 mM glucose. Hence culture at an intermediate glucose concentration enhanced, whereas culture at a high glucose concentration diminished the stimulatory effect of previous palmitate per se.
The inhibitory influence of palmitate, on the other hand, was not affected by increasing the glucose concentration during culture. Thus no difference was apparent in FFA-induced attenuation of 27 mM glucose-induced insulin release whether the culture medium contained 5.5, 11, or 27 mM glucose (Table  IV) . Also the magnitude of palmitate-induced decrease in insulin contents seemed unaffected by glucose concentration during culture, the decrease being additive to that brought about by culture with 27 mM glucose alone. Effect ofpalmitate on a-ketoisocaproic acid-induced insulin release. To examine the specificity of inhibition by fatty acids of glucose-induced insulin release, we tested the effects of palmitate during culture on subsequent release induced by 5 mM a-ketoisocaproic acid. In contrast to its inhibitory effect on glucose-induced insulin release, previous 0.125 mM palmitate failed to inhibit and even slightly increased a-ketoisocaproic acid-induced insulin secretion. Thus release after previous palmitate was 16±1.2 vs. 13±0.75 ng/ islet * 60 min during control conditions, P < 0.05).
Effects ofFFA on proinsulin and total protein biosynthesis in islets. Effects of 48 h of exposure to 0.125 mM palmitate or oleate on islet biosynthesis are shown in Table V . At 3.3 mM glucose neither palmitate nor oleate influenced incorporation of [3H ]leucine into proinsulin-insulin. However, incorporation at 27 mM glucose was inhibited by both fatty acids. Inhibition of the absolute rate of biosynthesis amounted to 40% for palmitate and 28% for oleate. Also the effects of glucose on total protein synthesis in the presence of 27 mM glucose were inhibited by palmitate and oleate. The inhibitory effects on total protein synthesis were no less than on proinsulin biosynthesis. Hence the fatty acids did not change the relative contribution of proinsulin synthesis to total protein synthesis.
Addition of 1 MAM etomoxir to culture media significantly reversed the inhibitory effects of palmitate and oleate on glu-cose-stimulated proinsulin biosynthesis. There was a tendency, albeit nonsignificant, for reversal of inhibition of total protein synthesis (Table V) .
Effects ofFFA on glucose oxidation. The rate ofD-[U-"4C]glucose oxidation at 3.3 mM of the hexose was not influenced by culture with palmitate or oleate (Table VI) . However, oxidation in the presence of 27 mM glucose was inhibited by 24% and 32% in islets cultured in medium containing respectively palmitate or oleate. The co-presence of 1 uM Etomoxir with palmitate or oleate in culture media restored the impaired oxidation rate to normal or near normal. The rate of D-[ 3,4-'4C]glucose was also studied in order to assess an influence ofFFA on the decarboxylation ofpyruvate.
The production of "'CO2 was decreased by culture with palmitate or oleate. The inhibitory effect amounted to 35% after palmitate and 39% after oleate. This inhibition was fully reversible by etomoxir.
Discussion
Our results show that exposure to fatty acids in vitro leads to profound inhibition of glucose-induced insulin secretion. To our knowledge, such an effect has not previously been documented in vitro. The absence of an inhibitory effect in other studies is explainable by the fact that short-term effects were usually investigated (2, 3, 22, 23) . Our study shows that induction of inhibition by FFA requires a long induction time, i.e., between 6 and 24 h.
Several observations indicate that the inhibitory effect of long-term FFA is not due to unspecific damage of B cell function. First, the effect was reversible upon removal of FFA on a time scale comparable with that for induction. Second, responses to another nutrient secretagogue, a-ketoisocaproic acid, were not inhibited. Third, an effect ofFFA on glucose-induced insulin release was rapidly reversible by etomoxir (see further below).
Our findings strongly indicate coupling between fatty acid oxidation and the time-dependent inhibition of glucose-induced insulin secretion. Etomoxir, which is a CPT I inhibitor ( 19, 20) , thus partially reversed the inhibitory effect of palmitate or oleate. The specificity of the etomoxir effect is highlighted by failure of the drug to significantly reverse the inhibition of glucose-induced insulin secretion caused by previous octanoate. By virtue ofbeing a medium chain fatty acid, octanoate is known to enter mitochondria and to be metabolized without involvement of the CPT I enzyme (21 ) .
We observed that etomoxir can reverse inhibition of glucose-induced insulin secretion not only when added during culture but also when added solely after culture in the absence of exogenous FFA. The efficiency of etomoxir when present solely after culture indicates the importance of breakdown of islet endogenous triacylglycerols for the inhibitory effect of FFA. The same mechanism (inhibition of utilization of FFA derived from endogenous triacylglycerols) should underlie at least in part the effects of etomoxir after its presence during culture. Thus etomoxir forms covalent bonds with the CPT I enzyme (19) (20) (21) causing irreversible inhibition ofthis enzyme. This leads to a prolonged effect of etomoxir which extends to the test period following culture. The failure of etomoxir to reverse inhibition by previous octanoate is probably due to the buildup oftriacylglycerols containing residues of octanoic acid during exposure to octanoate. Subsequent lipolysis would then yield predominantly such residues which can be transported into mitochondria for A-oxidation also in the presence of etomoxir.
The present study demonstrates an influence of long-term FFA not only on glucose-induced insulin secretion but, to our knowledge for the first time, an effect also on glucose-induced proinsulin and total protein biosynthesis in islets. The results with etomoxir indicate the importance of fatty acid oxidation also on this modality of glucose regulation. The findings on biosynthesis are compatible with the observed decrease in islet insulin content that was universally observed after FFA. Such decrease could also partially be explained by the increased insulin secretion which occurred after FFA exposure but before measurements of islet insulin contents.
Our data on glucose oxidation indicate that the inhibitory effects ofFFA on glucose-induced insulin secretion and biosynthesis are exerted at the level of glucose oxidation. In previous studies glucose oxidation has repeatedly been shown to be linked to the insulin-releasing potency of the hexose (24, 25) . In our experiments a 48-h culture with palmitate or oleate significantly decreased oxidation of D-[U-"4C] glucose, and this inhibition was reversed by etomoxir. Evidence obtained from other tissues indicate that inhibition of glucose metabolism by FFA is mainly exerted on the pyruvate dehydrogenase (PDH) enzyme complex (5) . The failure of previous FFA to affect the insulin response to a-ketoisocaproic acid is compatible with such notion since this nutrient is oxidized through the citric acid cycle without involvement of PDH. Also we find that production of "'CO2 from D- [3,4- '4C]glucose, which reflects the decarboxylation of pyruvate due to PDH activity, is depressed after long-term exposure to FFA.
In addition to the inhibitory effects of glucose-induced insulin secretion, FFA also exerted stimulatory effects on secretion. In the short-term perspective, such effects are well documented in previous studies (2, 3, 22, 23) . Such effects may be linked to mitochondrial oxidation and/or the breakdown in the cytoplasm oflong chain acyl-CoA esters to second messengers such as diacylglycerol (8) . The present study clearly shows that, in contrast to the inhibitory effects of FFA, a long induction time was not necessary for a stimulatory effect of previous FFA. However, the time of reversibility did not differ between the stimulatory and inhibitory effects. The similarity in reversibility could plausibly be due to increased endogenous triacylglycerols being present for an extended period of time after culture with FFA, such stores delivering the substrate necessary for the previously established influences of FFA.
It is interesting to note that variations in glucose concentra-tions during culture with FFA produced quite different results on secretion when the concentration ofglucose in final incubations was 27 as compared to 3.3 mM glucose. The inhibitory effect of FFA on the subsequent response to 27 mM glucose was thus similar regardless ofwhether the culture medium contained 3.3, 11, or 27 mM glucose. Conversely, the enhancement by previous FFA ofsecretion at basal glucose was obliterated by increasing the glucose concentration during culture from 11 to 27 mM. Ofpossible relevance to the latter effect are previous findings, showing (in short-term experiments) that a high glucose concentration decreases the oxidation of palmitate ( 1, 6, 26) .
What is the relevance of our results for in vivo conditions? The type of FFA and concentrations used bear on this question. The fact that our results were achieved using those fatty acids (palmitate and oleate) which are most common in rat and man supports relevance for in vivo conditions. Concerning concentrations, those of palmitate or oleate were about 25% of FFA in rat plasma (9) ; however, the non-protein-bound fraction was probably elevated since serum proteins including albumin, were only present in the 10% concentration ofthe fetal calf serum. The possible impact of these differences between culture medium and plasma on FFA effects remains to be evaluated.
Other observations support the notion that the long-term effects of FFA that we observed in vitro are operative in the B cell during physiological and pathophysiological conditions. First, and most important, several of the present findings are similar to our results in lipid-infused rats (9) . Also in the previous study, an induction period of more than 6 h was necessary to induce inhibition of glucose-induced insulin secretion. As in the present study, such inhibition was also specific for glucose-induced insulin secretion. Second, the effects ofa high fat diet resemble our results. Such a diet in diabetic mice leads to a decrease ofglucose-induced insulin secretion, biosynthesis, and oxidation (27) . Also, in suckling neonate rats (receiving a high fat nutrition), inhibition of FFA oxidation was shown to enhance glucose-induced insulin secretion (28) . Third, in the present study, the inhibitory effect of FFA was present also after co-culture with a high glucose concentration implying that inhibition would be operative also under diabetic conditions.
In summary, fatty acids time-dependently inhibit glucoseinduced insulin secretion and biosynthesis. The specificity of this effect, its linkage to fatty acid oxidation indicate that a glucose-fatty acid cycle is operative in the pancreatic B cells. Elevated FFA in the starved and diabetic state potentially participate in the evolution or persistence of B cell insensitivity.
